We are live on ! Find out more
VMD icon

Viemed Healthcare

112 hedge funds and large institutions have $159M invested in Viemed Healthcare in 2023 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 38 increasing their positions, 33 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

400% more call options, than puts

Call options by funds: $5K | Put options by funds: $1K

100% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 10

15% more repeat investments, than reductions

Existing positions increased: 38 | Existing positions reduced: 33

9% more funds holding

Funds holding: 103112 (+9)

2.2% less ownership

Funds ownership: 63.51%61.31% (-2.2%)

36% less capital invested

Capital invested by funds: $246M → $159M (-$87.7M)

75% less funds holding in top 10

Funds holding in top 10: 41 (-3)

Holders
112
Holders Change
+9
Holders Change %
+8.74%
% of All Funds
1.78%
Holding in Top 10
1
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-75%
% of All Funds
0.02%
New
20
Increased
38
Reduced
33
Closed
10
Calls
$5K
Puts
$1K
Net Calls
+$4K
Net Calls Change
-$81K
Name Holding Trade Value Shares
Change
Change in
Stake
SRCM
51
Sage Rock Capital Management
New York
$309K +$186K +22,700 +97%
JC
52
JBF Capital
Colorado
$292K
RhumbLine Advisers
53
RhumbLine Advisers
Massachusetts
$256K +$14K +1,713 +5%
BA
54
Bard Associates
Illinois
$232K +$86.3K +10,530 +44%
ACA
55
Anchor Capital Advisors
Massachusetts
$223K
Bank of America
56
Bank of America
North Carolina
$214K +$93.2K +11,381 +56%
OAM
57
Oppenheimer Asset Management
New York
$201K -$44.6K -5,441 -15%
National Bank of Canada
58
National Bank of Canada
Quebec, Canada
$199K -$1.97K -241 -0.8%
SOW
59
State of Wyoming
Wyoming
$164K +$199K +24,317 New
MAM
60
Martingale Asset Management
Massachusetts
$163K +$199K +24,280 New
SIC
61
Salem Investment Counselors
North Carolina
$161K
JP Morgan Chase
62
JP Morgan Chase
New York
$157K -$27.1K -3,302 -12%
William Blair & Company
63
William Blair & Company
Illinois
$155K
CCIA
64
Campbell & Co Investment Adviser
Maryland
$154K -$50.5K -6,159 -21%
Deutsche Bank
65
Deutsche Bank
Germany
$150K +$29.8K +3,639 +20%
BA
66
BCM Advisors
Louisiana
$148K
UBS Group
67
UBS Group
Switzerland
$124K -$48.8K -5,960 -24%
MIM
68
MetLife Investment Management
New Jersey
$122K
Qube Research & Technologies (QRT)
69
Qube Research & Technologies (QRT)
United Kingdom
$121K +$147K +17,920 New
Marshall Wace
70
Marshall Wace
United Kingdom
$118K +$144K +17,600 New
Mirae Asset Global Investments
71
Mirae Asset Global Investments
South Korea
$117K
AIG
72
American International Group
New York
$115K +$4.96K +605 +4%
OSAM
73
O'Shaughnessy Asset Management
Connecticut
$113K -$57.7K -7,040 -30%
Walleye Capital
74
Walleye Capital
New York
$104K -$6.74K -823 -5%
VOYA Investment Management
75
VOYA Investment Management
Georgia
$103K +$6.55K +800 +6%

VMD Hedge Fund Activity: Q3 2023 in Review

112 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Viemed Healthcare (VMD) for Q3 2023, worth a combined $159M — down 36% from $246M a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new VMD positions and 10 closed out — a net gain of 10 holders — while 38 added to existing stakes and 33 trimmed.

The largest buyer was Nantahala Capital Management, adding an estimated $2.49M. The largest seller was Hillsdale Investment Management, cutting an estimated $5.66M.

  • 112 institutional investors held Viemed Healthcare (VMD) as of Q3 2023, up from 103 in Q2 2023.
  • Funds reported $159M of Viemed Healthcare stock for Q3 2023, down 36% quarter-over-quarter.
  • 20 funds opened new Viemed Healthcare positions in Q3 2023 and 10 closed out, a net change of +10 holders.
  • The largest Viemed Healthcare buyer in Q3 2023 was Nantahala Capital Management, an estimated $2.49M added.
  • The largest Viemed Healthcare seller in Q3 2023 was Hillsdale Investment Management, an estimated $5.66M sold.

Based on aggregated 13F filings for Q3 2023.